medigraphic.com
SPANISH

CorSalud (Revista de Enfermedades Cardiovasculares)

ISSN 2078-7170 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 4

<< Back Next >>

CorSalud 2015; 7 (4)

Acute myocardial infarction after subcutaneous administration of sumatriptan

Rodríguez LLA, Rodríguez ME, Gavilánez HR, Milord FY, Ercia AJM, Triana DA, Cuéllar GÁ
Full text How to cite this article

Language: Spanish
References: 12
Page: 322-325
PDF size: 290.71 Kb.


Key words:

myocardial infarction, coronary vasoconstriction, sumatriptan.

ABSTRACT

Sumatriptan is a drug used for migraine which can produce coronary vasoconstriction. The case of a 50-year-old male with no history of cardiovascular disease who suffered an acute myocardial infarction, of non-atherosclerotic cause, as a result of the subcutaneous administration of this drug is reported. The patient did not show complications after drug withdrawal.


REFERENCES

  1. Hillis WS, Macintyre PD. Sumatriptan and chest pain. Lancet. 1993;342:683.

  2. Visser WH, de Vriend RH, Jaspers MW, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology. 1996;47:46-51.

  3. Szabo CP. Fluoxetine and sumatriptan: possibly a counterproductive combination. J Clin Psychiatry. 1995;56:37-8.

  4. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1994;47:622-51.

  5. Mathew NT, Dexter J, Couch J, Flamenbaum W, Goldstein J, Rapoport A,et al. Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Re-search Group. Arch Neurol. 1992;49:1271-6.

  6. Hämäläinen ML, Hoppu K, Santavuori P. Sumatrip-tan for migraine attacks in children: a randomized placebo-controlled study. Do children with mi-graine respond to oral sumatriptan differently from adults? Neurology. 1997;48:1100-3.

  7. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:1507-10.

  8. Shuhaiber S, Pastuszak A, Schick B, Matsui D, Spivey G, Brochu J, et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology. 1998;51:581-3.

  9. Hodge JA, Hodge KD. Ischemic colitis related to sumatriptan overuse. J Am Board Fam Med. 2010;23: 124-7.

  10. 10.Boyd IW, Rohan AP. Sumatriptan-induced chest pain. Lancet. 1994;344:1704-5.

  11. 11.Santos Y, Pérez JA, Mata A, Rivero Y, Roque JJ. Un caso de síndrome de Kounis en Sagua La Grande. CorSalud [Internet]. 2014 [citado 29 Jun 2015];6: 201-4. Disponible en: http://www.bvs.sld.cu/revistas/cors/sumario/2014 /v6n2a14/kounis.html

  12. 12.Gómez Canosa MS, Castro Orjales MJ, Rodríguez Fariñas FJ, García Jiménez A, Gutiérrez Cortés JM. Tratamiento del síndrome de Kounis. Med Intensiva. 2011;35:519-20.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

CorSalud. 2015;7